Havens Advisors’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Havens Advisors’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-67,963	Closed	-$2.3M	–	59
2021 Q2	$2.3M	Buy	+67,963	New	+$1.73M	1.82%	18

Havens Advisors's CNST Position: Q3 2021 in Review

Havens Advisors sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 67,963 shares — an estimated $2.3M sold.

Havens Advisors first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $2.3M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Havens Advisors reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Havens Advisors sold 67,963 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $2.3M.
Havens Advisors first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Havens Advisors's Constellation Pharmaceuticals, Inc. position peaked at $2.3M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Havens Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.